Treatment of male sexual dysfunction with integrated traditional Chinese and Western Medicine
summary
No normal erection, no natural stimulation of erectile response, penile weakness, no sensory response, glans numbness, no sexual desire, low sensitivity, morning surge disappeared. The doctor said that this is sexual dysfunction, which is much better now. Here I would like to share with you the treatment of male sexual dysfunction with integrated traditional Chinese and Western medicine, hoping to help more people.
Treatment of male sexual dysfunction with integrated traditional Chinese and Western Medicine
Treatment 1: change the sexual intercourse movement, from slow to urgent, reduce the large range of movement, in order to delay ejaculation.
Treatment 2: surgical treatment, penile prosthesis implantation: the final choice for patients with severe erectile dysfunction and other treatment is invalid. Due to the improvement of prosthesis performance and surgical skills, the long-term effective rate of skilled doctors is very high. In recent years, there are many kinds of prosthesis for the treatment of erectile dysfunction, but its expensive and surgical operation and do not understand the prosthesis and other reasons, only about 7% of patients with erectile dysfunction received prosthesis implantation.
Treatment 3: Gentianaceae 15 g, Scutellaria 10 g, gardenia 9 g, Alisma 12 g, Akebia 10 g, Plantago 9 g, angelica 10 g, Shengdi, licorice 9 G. Decoction, 1 dose per day, twice a day.
matters needing attention
Warm tips: the relationship between cardiovascular disease and erectile dysfunction is more positive, and erectile dysfunction occurs in one third of men over 40 years old with hypertension. Hypertension not only damages the peripheral small blood vessels and affects the hemodynamic changes of the corpus cavernosum, but also many antihypertensive drugs affect the relaxation function of the smooth muscle of the corpus cavernosum and induce erectile dysfunction. The change of erectile function in patients with joifa tube disease may be the initial clinical manifestation of systemic atherosclerosis, so the cardiovascular status of patients should be evaluated before treatment.
